Home Monitoring in Cardiac Resynchronisation Therapy

NCT ID: NCT00376116

Last Updated: 2008-11-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

513 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-03-31

Study Completion Date

2008-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In spite of success in the management of heart failure, repetitive rehospitalisation and high mortality rate remain a serious problem. Recent studies, especially the COMPANION trial, have demonstrated that cardiac resynchronisation therapy (CRT) reduces mortality and rehospitalisation in heart failure patients. There is also evidence that telemonitoring of heart failure patients potentially reduces both mortality and morbidity. Recently, a Home Monitoring (HM) function has been integrated into BIOTRONIK CRT-defibrillators and CRT-pacemakers with a view of harnessing the powerful combination of CRT with close remote monitoring of heart failure patients. It is possible now to transmit predefined parameters on a daily basis from the implanted devices to a web-based platform accessible by patients' physicians. Our study evaluates clinical usefulness of Biotronik HM function in CRT-defibrillators and CRT-pacemakers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Clinical investigations identified potential predictors for mortality and rehospitalisation events in heart failure patients. A selection of these predictors primarily composes the "Heart Failure Monitor" (HFM), which is implemented in Biotronik implantable cardioverter defibrillators (ICDs) capable of delivering cardiac resynchronisation therapy (CRT) as well as in CRT-pacemakers. HFM and other parameters are transmitted to the attending physician via Home Monitoring (HM) function integrated in the implanted devices. In the future, a HFM with high predictive power may play an important role as part of a strategy of delivering effective health care for heart failure patients with an indication for CRT.

Our included patients implanted with CRT devices STRATOS LV-T (CRT-pacemaker), KRONOS LV-T, or Lumax HF-T (CRT-ICD). Pre-discharge protocol comprised standard device follow-up, activation of the HM-function, and assessment of complications and cardiovascular events. At follow-up controls 1, 3, 6, 9, and 12 months after implantation, standard device follow-up was performed and complications and cardiovascular events were assessed.

At enrollment, 6 and 12 months postoperative and in case of a rehospitalisation, the following parameters are documented:

* Echocardiographic parameters
* Quality of Life (Minnesota)
* ECG-parameters, NYHA-classification
* Blood pressure, body weight
* BNP / NT-pro BNP (optional)
* 6 minute walk test (optional)

At 1, 3 and 9 months postoperative:

* ECG-parameters, NYHA-classification
* Blood pressure, body weight
* BNP / NT-pro BNP (optional)
* 6 minute walk test (optional)

Further documentation:

* Change of drug treatment
* Any cardiovascular event and therapeutic intervention
* Heart failure related symptoms by means of patient diary

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure, Congestive

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Implantable cardioverter-defibrillator Pacemaker Cardiac resynchronisation therapy Heart failure Predictor Mortality Rehospitalization Telemedicine Home Monitoring

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cardiac resynchronisation therapy

Intervention Type DEVICE

Implantable cardioverter-defibrillator

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Written patient informed consent
* Indication for CRT (biventricular or bifocal)
* Sufficient GSM-network coverage in the patient's area
* Stable residence during follow-up (anticipated)
* at least 1 documented hospitalisation due to heart failure within 12 months before enrolment

Exclusion Criteria

* Permanent atrial fibrillation
* Myocardial infarction or instable Angina Pectoris within the last 3 months
* Planned cardiac interventions within the next 3 months (e.g. PTCA, CABG, HTX)
* Acute myocarditis
* Life expectancy under 6 months
* Pregnant or breast-feeding woman
* Participation in another clinical study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Biotronik SE & Co. KG

INDUSTRY

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stefan Sack, Associate Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

Division of Cardiology, University of Essen, Germany

Vincent Paul, MD

Role: PRINCIPAL_INVESTIGATOR

Cardiology Department, St. Peter's Hospital, Chertsey Surrey, United Kingdom

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

LKH-Universitätsklinikum Graz

Graz, , Austria

Site Status

Medizinische Universität Wien

Vienna, , Austria

Site Status

Fakultni nemocnice u Svety Anny

Brno, , Czechia

Site Status

IKEM

Prague, , Czechia

Site Status

Petr Neuzil M.D., Ph.D.

Prague, , Czechia

Site Status

Centre Hospitalier Universitaire d'Angers

Angers, , France

Site Status

Hôpital Cardiologique du Haut Lévêque

Bordeaux, , France

Site Status

CHU de Lyon - Hôpital Louis Pradel

Lyon, , France

Site Status

Groupe Hospitalier de la Timone

Marseille, , France

Site Status

CHRU Hôpital de Villeneuve, Cardiologie A

Montpellier, , France

Site Status

CHRU Hôpital de Villeneuve, Cardiologie B

Montpellier, , France

Site Status

Centre Hospitalier

Pau, , France

Site Status

Hôpital haut Lévêque

Pessac, , France

Site Status

CHU des Rennes

Rennes, , France

Site Status

Universitätsklinik der RWTH Aachen

Aachen, , Germany

Site Status

Helios Klinikum Aue GmbH

Aue, , Germany

Site Status

Zentralklinik Bad Berka GmbH

Bad Berka, , Germany

Site Status

Krankenhaus Bassum

Bassum, , Germany

Site Status

Evangelisches Krankenhaus

Bergisch Gladbach, , Germany

Site Status

Gemeinschaftpraxis für Kardiologie und Angiologie

Bergisch Gladbach, , Germany

Site Status

Universitätsklinikum Charité

Berlin, , Germany

Site Status

Ambulantes Herzzentrum

Berlin, , Germany

Site Status

Franz-Volhard-Klinik

Berlin, , Germany

Site Status

Campus Virchow Klinikum, Charité

Berlin, , Germany

Site Status

Vivantes Netzwerk für Gesundheit GmbH

Berlin, , Germany

Site Status

Städtische Kliniken Bielefeld gGmbH

Bielefeld, , Germany

Site Status

Berufsgenossenschaftliche Kliniken Bergmannsheil

Bochum, , Germany

Site Status

Praxisgemeinschaft

Braunschweig, , Germany

Site Status

Städtisches Klinikum Braunschweig gGmbH

Braunschweig, , Germany

Site Status

Zentralkrankenhaus Links der Weser

Bremen, , Germany

Site Status

Kardiologische Gemeinschaftspraxis

Chemnitz, , Germany

Site Status

Klinikum Coburg

Coburg, , Germany

Site Status

Herzzentrum Coswig

Coswig, , Germany

Site Status

Carl-Thiem-Klinikum

Cottbus, , Germany

Site Status

Cardiac Research GmbH

Dortmund, , Germany

Site Status

Städtisches Klinikum Dresden-Friedrichstadt

Dresden, , Germany

Site Status

Praxiszentrum Herzkreislauf

Dresden, , Germany

Site Status

Evangelisches Krankenhaus

Düsseldorf, , Germany

Site Status

Helios Klinikum Erfurt

Erfurt, , Germany

Site Status

Universitätsklinikum Essen

Essen, , Germany

Site Status

Elisabeth Krankenhaus Essen

Essen, , Germany

Site Status

Klinikum Frankfurt/Oder GmbH

Frankfurt (Oder), , Germany

Site Status

Ernst-Moritz-Arndt Universität Greifswald

Greifswald, , Germany

Site Status

Allgemeines Krankenhaus Altona

Hamburg, , Germany

Site Status

Kardiologische Gemeinschaftspraxis

Hanover, , Germany

Site Status

Universitätsklinikum Heidelberg

Heidelberg, , Germany

Site Status

Praxis Dr. med. Natour

Heidelberg, , Germany

Site Status

Medizinische Universitätsklinik Homburg/Saar

Homburg/Saar, , Germany

Site Status

Klinikum Hoyerswerda

Hoyerswerda, , Germany

Site Status

Gemeinschaftspraxis Dr. Kroll/Dr. Rebeski

Kiel, , Germany

Site Status

Herzzentrum Konstanz GmbH

Konstanz, , Germany

Site Status

PD Dr. Christoph Karle

Künzelsau, , Germany

Site Status

Städtisches Klinikum St. Georg

Leipzig, , Germany

Site Status

Herzzentrum Leipzig GmbH

Leipzig, , Germany

Site Status

Märkische Kliniken GmbH

Lüdenscheid, , Germany

Site Status

Klinikum Johannes-Gutenberg-Universität

Mainz, , Germany

Site Status

Praxis Dr. Patrizia Kindler

Meiningen, , Germany

Site Status

Kliniken Maria Hilf GmbH

Mönchengladbach, , Germany

Site Status

Stiftsklinik Augustinum

München, , Germany

Site Status

Ruppiner Klinikum GmbH

Neuruppin, , Germany

Site Status

Klinikum Pirna GmbH

Pirna, , Germany

Site Status

St. Adolf-Stift

Reinbek, , Germany

Site Status

St. Elisabeth Klinik

Saarlouis, , Germany

Site Status

Kardiologische Gemeinschaftspraxis Dr. Hoh u. Dr. Tamm

Wittenberg/Lutherstadt, , Germany

Site Status

Universitätsklinikum Würzburg

Würzburg, , Germany

Site Status

Haemek Medical Center

Afula, , Israel

Site Status

Barzilai Medical Center, ICCU

Ashkelon, , Israel

Site Status

Ben Gurion University

Beersheba, , Israel

Site Status

Hadasit Medical Research Services & Development Ltd.

Jerusalem, , Israel

Site Status

Rabin Medical Center

Petah Tikva, , Israel

Site Status

Azienda Ospedaliera "Santi Antonio e Biagio e Cesare Arrigo

Allessandria, , Italy

Site Status

P. Stradina Clinical University Hospital

Riga, , Latvia

Site Status

VU Amsterdam

Amsterdam, , Netherlands

Site Status

Erasmus Medical Center

Rotterdam, , Netherlands

Site Status

Zaandam Medisch Centrum

Zaandam, , Netherlands

Site Status

Hospital Nra. Sra. de Sonsoles

Ávila, , Spain

Site Status

Selly Oak Hospital

Birmingham, , United Kingdom

Site Status

St. Peter's Hospital / St. George's

Chertsey, , United Kingdom

Site Status

Russels Hall Hospital

Dudley, , United Kingdom

Site Status

University of Hull

Hull, , United Kingdom

Site Status

Good Hope

Sutton Coldfield, , United Kingdom

Site Status

Swansea NHS Trust

Swansea, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria Czechia France Germany Israel Italy Latvia Netherlands Spain United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Ellery S, Pakrashi T, Paul V, Sack S. Predicting mortality and rehospitalization in heart failure patients with home monitoring--the Home CARE pilot study. Clin Res Cardiol. 2006;95 Suppl 3:III29-35. doi: 10.1007/s00392-006-1306-6.

Reference Type BACKGROUND
PMID: 16598601 (View on PubMed)

Sack S, Wende CM, Nagele H, Katz A, Bauer WR, Barr CS, Malinowski K, Schwacke H, Leyva F, Proff J, Berdyshev S, Paul V. Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study. Eur J Heart Fail. 2011 Sep;13(9):1019-27. doi: 10.1093/eurjhf/hfr089.

Reference Type DERIVED
PMID: 21852311 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TA056

Identifier Type: -

Identifier Source: org_study_id